Medtronic Posts Profit Of 97 Cents Per Share.

MEDTRONIC REPORTS SECOND QUARTER FISCAL 2022 FINANCIAL RESULTS.
Q2 NON-GAAP EARNINGS PER SHARE $1.32.
Q2 GAAP EARNINGS PER SHARE $0.97.
REAFFIRMS FY NON-GAAP EARNINGS PER SHARE VIEW $5.65 TO $5.75 INCLUDING ITEMS.MARKET PROCEDURE VOLUMES IMPACTED BY COVID-19 RESURGENCE.
Q2 REVENUE RESULTS REFLECT UNFAVORABLE MARKET IMPACT OF COVID-19 AND HEALTH SYSTEM LABOR SHORTAGES ON MEDICAL DEVICE PROCEDURE VOLUMES.
QTRLY REVENUE OF $7.8 BILLION INCREASED 3% REPORTED.
QTRLY CARDIOVASCULAR REVENUE OF $2.827 BILLION INCREASED 4% AS REPORTED AND 3% ORGANIC.
QTRLY MEDICAL SURGICAL REVENUE OF $2.299 BILLION INCREASED 1% AS REPORTED AND WAS FLAT ORGANIC.
EXPECT MARKETS TO CONTINUE TO BE AFFECTED BY PANDEMIC IN SECOND HALF OF OUR FISCAL YEAR.
Q2 EARNINGS PER SHARE VIEW $1.29, REVENUE VIEW $7.96 BILLION -- REFINITIV IBES DATA.
EXCLUDING IMPACT OF VENTILATOR SALES DECLINES, QTRLY MEDICAL SURGICAL REVENUE INCREASED 6% ORGANIC.
FY2022 EARNINGS PER SHARE VIEW $5.71, REVENUE VIEW $32.97 BILLION -- REFINITIV IBES DATA.
QTRLY NEUROSCIENCE REVENUE OF $2.136 BILLION INCREASED 4% AS REPORTED AND 3% ORGANIC.